𩺠å
§ç§å°ç§èåç
ð äžé éé»
- 22E 匷調ïŒsmall fiber neuropathy èªå¯
- Diabetic peripheral neuropathy æ²»çïŒduloxetine, pregabalin first
- Vasculitic neuropathy æ©èŸšè
- Long COVID neuropathy æ
ð§ é²éæ©èœ
Small Fiber Neuropathy
- C, A-delta fibers
- NCS æ£åžžäœççæ
- DiagnosticïŒskin biopsy with intraepidermal nerve fiber density (IENFD)
- ç
å ïŒDM, autoimmune, viral, idiopathic, sodium channelopathy
CIDP (Chronic Inflammatory Demyelinating Polyneuropathy)
8 weeks progressive
- Demyelinating on NCS
- IVIG / plasmapheresis / steroid
Mononeuritis Multiplex
- Multiple non-contiguous nerves
- VasculiticïŒPAN, EGPA, ANCA, RA, SLE, hep B/C, HIVïŒ
- Nerve biopsy 確蚺
- Treat underlying
Hereditary Neuropathy
- CMT (Charcot-Marie-Tooth)
- Type 1 demyelinating, type 2 axonal
- PMP22 duplication (CMT1A æåžž)
- Pes cavus + é«åŒè¶³
ð æ²»ç
Painful Neuropathy
- First-line: duloxetine, pregabalin, gabapentin, TCA
- Second: tramadol
- Topical: lidocaine, capsaicin
- Avoid long-term opioid
CIDP
- IVIG 2 g/kg load â maintenance
- Plasmapheresis
- Steroid
Carpal Tunnel
- Splint > steroid > surgery
- Open vs endoscopic release
ð Pearls (8)
- NCS æ£åžž + çç = æ³ small fiber
- Mononeuritis multiplex â vasculitic workup
- CMT ç family + pes cavus
- CIDP > 8 wk distinguish from GBS
- Long-term metformin â B12 monitor
- PPI long-term â B12 â
- Vegans â B12 supplement
- Painful DPN: duloxetine first
ð ç¹æ®æ
å¢
- HIV neuropathy: distal symmetric + treatment-related
- Chemo (cisplatin, vincristine, paclitaxel)
- Paraneoplastic (anti-Hu)
- POEMS syndrome
- Amyloid neuropathy
ð å°ç£ Context
- DPN å¥ä¿
- IVIG for CIDP å¥ä¿
- Skin biopsy éšåäžå¿
- Nerve biopsy éå®äžå¿
- TFAP (transthyretin amyloidosis): patisiran, inotersen, vutrisiran
â ïž èéå°é·å
- Saddle æŒ cauda equina
- B12 äžæ¥
- Long-term metformin / PPI äžèŠèŠº
- Painful DPN 絊 opioid 䞻治
- Vasculitic äžè©äŒ°
- CIDP ç¶ GBS
ð å
§å°éé»
- Patterns 6 çš®
- Cord syndromes
- Painful neuropathy æ²»ç
- CIDP / GBS åå
- Small fiber
è·šç« ç¯
- Ch 26 Weakness
- Ch 28 Gait
- Ch 421 DPN
- Ch 444 Peripheral neuropathy
ð 玢åŒ
â ïž AI èçš¿ã